Clinical trials
Phase 3 trials in Belarus
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
191 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 3 |
| 2004 | 3 |
| 2006 | 2 |
| 2007 | 8 |
| 2008 | 17 |
| 2009 | 14 |
| 2010 | 13 |
| 2011 | 10 |
| 2012 | 9 |
| 2013 | 9 |
| 2014 | 16 |
| 2015 | 9 |
| 2016 | 12 |
| 2017 | 16 |
| 2018 | 15 |
| 2019 | 13 |
| 2020 | 13 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 153 |
| Active, not recruiting | 20 |
| Terminated | 12 |
| Unknown status | 3 |
| Recruiting | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sanofi | 19 |
| Actelion | 13 |
| AbbVie | 12 |
| Biocad | 11 |
| Celgene | 8 |
| Hoffmann-La Roche | 5 |
| Astellas Pharma Europe B.V. | 4 |
| Astellas Pharma Inc | 4 |
| CSL Behring | 4 |
| Ambrilia Biopharma, Inc. | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 12 |
| Multiple Sclerosis | 12 |
| Carcinoma, Non-Small-Cell Lung | 11 |
| Crohn Disease | 10 |
| Arthritis, Rheumatoid | 8 |
| Colitis, Ulcerative | 8 |
| Pulmonary Arterial Hypertension | 8 |
| Multiple Sclerosis, Relapsing-Remitting | 7 |
| Venous Thromboembolism | 7 |
| Neoplasms | 5 |
Trials
Showing 1 to 25 of 191. Each trial links to its page on Pharma Observatory.
91 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.